1. P1552High cardiovascular risk is associated with the degree of fibrosis in non alcoholic fatty liver disease. (28th August 2018) Authors: Niederseer, D; Stadlmayr, A; Huber-Schoenauer, U; Lederer, D; Schmied, C M; Ploederl, M; Aigner, E; Patsch, W; Datz, C Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M28 Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation. (15th November 2017) Authors: Maher, T; Jouneau, S; Morrison, L; Lederer, D; Molina-Molina, M; Kirchgaessler, K-U; Gilberg, F; Axmann, J; Petzinger, U; Bendstrup, E Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RSK2 mutation co‐segregates with X‐linked intellectual disability and attenuated Coffin–Lowry phenotype in a three‐generation family. (17th March 2013) Authors: Maystadt, I; Destree, A; Benoit, V; Aeby, A; Lederer, D; Moortgat, S; Jurkiewicz, D; Krajewska‐Walasek, M; Hanauer, A; Thomas, GM Journal: Clinical genetics Issue: Volume 85:Number 1(2014:Jan.) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗